Tuesday, October 3, 2023
Tuesday, October 3, 2023

Contact: 561.316.3330

MindPortal Raises $5 Million

MindPortal creators of the next personal computer that is a wearable non-invasive brain-computer interface, announced today it completed a $5 Million seed round of financing.

Learn Capital led the round, with additional investment from Kleiner Perkins; Dan Siroker, Founder & CEO of Scribe AI; Matt Bellamy, rockstar and frontman of Muse; James Park, Co-Founder & CEO of Fitbit; Julie Zhou, Co-Founder of Sundial and former Vice President of Product Design for Facebook; Scrum Ventures; and additional angels from frontier tech, hardware and product design. Previous pre-seed investors included 7pc and Y Combinator. The new funding will be used to hire additional neuroscientists, product engineers and machine learning experts.

Presently, MindPortal’s patent pending wearable device can record human brain activity in real time, without surgery, with 10-100x more precision than EEG technology. The platform brain computer being developed will act as a bi-directional portal; connecting the mind to immersive, creative and playful experiences and also as a gateway into the mind. When wearing MindPortal’s device, people will be able to create and share new experiences e.g. in VR/AR, just by using their thoughts, and channel experiences into their mind.

“We’re animated by a vision of the future where every human on the planet has a greater opportunity to fully develop their talents and minds,” said Rob Hutter, Founder & Managing Partner of Learn Capital. “MindPortal is pursuing what some would call the holy grail – namely, a portable and non-invasive platform that samples brain activity at high spatial and temporal resolution, a technical feat that could unleash the potential for a dramatic improvement in productivity across work, play and life.”

“All technology has been generated from the ingenuity of the human mind, but for the first time in the history of our species, we are turning that ingenuity towards creating technology that enhances the human mind itself,” Ekram Alam, Co-founder & CEO of MindPortal.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

Theradaptive Awarded DOD Clinical Trial Award of up to $7.4 Million

Commenting on the award, Theradaptive CEO and founder, Luis Alvarez, Ph.D. said, "The CDMRP Clinical Trial Award comes at a pivotal time for our company as we prepare for first in human clinical trials. Veterans and service members are disproportionally likely to suffer from traumatic extremity injuries or spinal degeneration and disc injury, and currently lack efficacious treatments with very few options. We have already demonstrated superior outcomes in preclinical studies, showing the promise of our technology. With this CTA award we are one step closer to providing new and improved therapies to patients and aligning with CDMRP's strategic goal of trying to increase post-injury quality of life by halting or slowing orthopedic disease progression in servicemembers and veterans."

Lipogems® Announces 140 Independent Peer Reviewed Publications with 5 Years of Follow up in Orthopaedics

Giorgio Ninzoli, President of Lipogems International. "The gold standard for evidence is 1 year follow up and we are excited to report 5 years follow up with positive results after a single injection of MicroFat."

Study Outcomes Could Provide Insights Into New Targeted Treatments to Manage this Challenging Disease

The study aims to determine if immediate biological preservation of patient-derived chordoma tumor tissue, collected intraoperatively and implanted for serial sampling in translational research, will provide new insights into the biological weakness of the disease and contribute to developing improved treatment therapies reports NICO.

Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening

Utilizing Lunit INSIGHT MMG, an FDA-cleared and CE-marked AI solution for mammography analysis, this research backs AI's potential to replace one human reader under Europe's double reading guideline and underscores its capacity to alleviate the strain on radiologists.

By using this website you agree to accept Medical Device News Magazine Privacy Policy